The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer

In conclusion, hypoxia promoted the expansion of CSCs expressing CD133 and CD44 accompanied by an increase of stem cell factors. Its inhibition of hypoxia-induced CSC expansion makes TX-402 promising agent usable in combination for ovarian cancer therapy.